Clinical trial
Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young…
NCT00478621 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00478621 |
|---|---|
| Title | Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A) |
| Official title | A Multicentre Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' HPV Vaccine (GSK1674330A) in Healthy Female Subjects Aged 18-25 Years. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Infections, Papillomavirus |
| Intervention type | Biological |
| Interventions | GSK Biologicals' HPV vaccine (GSK1674330A), Cervarix TM |
| Enrollment | 540 |
| Start date | May 25, 2007 |
| Primary completion | Jun 30, 2008 |
| Completion | Oct 13, 2008 |
| First posted | May 25, 2007 |
| Last update posted | May 10, 2017 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: